Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thermo Fisher Scientific

http://www.thermofisher.com

Latest From Thermo Fisher Scientific

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances

The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and experts reveal what they are most excited about on the technology front.

Scrip Asks Innovation

Contrast Agent, Liquid Biopsy Tool Or Treatment? Earli Might Deliver All Three At Once

The company has developed a technology that uses engineered DNA to reprogram cancer cells, forcing them to produce substances that could be used to help image, detect or even destroy them.

Platform Technologies Cancer

REMS Vendor Disruptions Prompt Greater US FDA Scrutiny

McKesson’s exit from the space forced sponsors to switch vendors managing their REMS programs, which in some instances affected patient access to drugs. Omnibus legislation requires GAO report and collection of public input on factors FDA should consider in reviewing vendor changes.

Drug Safety FDA

JPM 2023: Novocure Announces Trial Results; ResMed Expands Manufacturing; Abbott's IVD Bet Pays Off

The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies; Some use the conference as a platform for major announcements while some just take the opportunity to explain their 2023 outlook to investors. Here are some of the highlights from the presentations on the second day of the meeting.

Approvals Business Strategies
See All

Company Information

  • Industry
  • Laboratory Testing Services
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • AcroMetrix Inc.
    • Affymetrix, Inc.
    • Alfa Aesar
    • Banner Pharmacaps
    • BioTrove
    • Brammer Bio
    • Core Informatics
    • DPx Holdings B.V.
    • Eureka Genomics Corporation
    • FEI Company
    • Fermentas International Inc.
    • Fisher Scientific
    • Gallu BioPharmaceuticals, LLC
    • Gatan, Inc.
    • Henogen S.A.
    • INEL Inc.
    • IRIX Pharmaceuticals
    • Life Technologies
    • Microgenics Corporation
    • Nanobac Pharmaceuticals
    • One Lambda, Inc.
    • Patheon, Inc.
    • Phadia US Inc.
    • PPD, Inc.
    • Thermo Scientific
    • Unity Lab Services
    • Zymed Inc.
UsernamePublicRestriction

Register